To the editor regarding article "Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study"

被引:0
|
作者
Mayer, Florian J. [1 ]
Pesau, Gerfried [2 ]
Schernthaner, Gerit H. [2 ]
机构
[1] Med Univ Vienna, Dept Lab Med, Vienna, Austria
[2] Med Univ Vienna, Div Angiol, Dept Internal Med 2, Vienna, Austria
来源
关键词
RESISTANCE; DISEASE;
D O I
10.1186/s13098-018-0394-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 33 条
  • [31] Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm
    Miyagi, Masahiko
    Uchino, Hiroshi
    Kumashiro, Naoki
    Higa, Mariko
    Shin, Koki
    Sasamoto, Makiko
    Kitazato, Hiroji
    Tamaki, Motoyuki
    Matsuhisa, Munehide
    Hirose, Takahisa
    DIABETES THERAPY, 2018, 9 (05) : 1959 - 1968
  • [32] Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm
    Masahiko Miyagi
    Hiroshi Uchino
    Naoki Kumashiro
    Mariko Higa
    Koki Shin
    Makiko Sasamoto
    Hiroji Kitazato
    Motoyuki Tamaki
    Munehide Matsuhisa
    Takahisa Hirose
    Diabetes Therapy, 2018, 9 : 1959 - 1968
  • [33] Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study (vol 30, pg 424, 2024)
    Lin, Yi-Hsuan
    Lin, Chia-Hung
    Lin, Yu-Chih
    Huang, Yu-Yao
    Tai, An-Shun
    Fu, Shih-Chen
    Lin, Sheng-Hsuan
    ENDOCRINE PRACTICE, 2024, 30 (09) : 898 - 898